Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Paolo Lissoni. (2017) Therapy implications of the role of interleukin-2 in cancer. Expert Review of Clinical Immunology 13:5, pages 491-498.
Read now
Read now
Rossana Tallerico, Costanza M. Cristiani, Elina Staaf, Cinzia Garofalo, Rosa Sottile, Mariaelena Capone, Yago Pico de Coaña, Gabriele Madonna, Eleonora Palella, Maria Wolodarski, Valentina Carannante, Domenico Mallardo, Ester Simeone, Antonio M. Grimaldi, Sofia Johansson, Paolo Frumento, Elio Gulletta, Andrea Anichini, Francesco Colucci, Gennaro Ciliberto, Rolf Kiessling, Klas Kärre, Paolo A. Ascierto & Ennio Carbone. (2017) IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients. OncoImmunology 6:2.
Read now
Read now
Articles from other publishers (52)
Andrea Jazel Rodriguez-Herrera, Ana Beatriz Farias de Souza, Thalles de Freitas Castro, Pedro Alves Machado-Junior, Elena Cecilia Marcano-Gomez, Tatiana Prata Menezes, Maria Laura da Cruz Castro, André Talvani, Daniela Caldeira Costa, Sílvia Dantas Cangussú & Frank Silva Bezerra. (2023) Long-term e-cigarette aerosol exposure causes pulmonary emphysema in adult female and male mice. Regulatory Toxicology and Pharmacology 142, pages 105412.
Crossref
Crossref
Efthymia Papaevangelou, Ana M. Esteves, Prokar Dasgupta & Christine Galustian. (2023) Cyto-IL-15 synergizes with the STING agonist ADU-S100 to eliminate prostate tumors and confer durable immunity in mouse models. Frontiers in Immunology 14.
Crossref
Crossref
Sabina Di Matteo, Enrico Munari, Piera Filomena Fiore, Silvia Santopolo, Camilla Sampaoli, Andrea Pelosi, Salem Chouaib, Nicola Tumino, Paola Vacca, Francesca Romana Mariotti, Stefan Ebert, Markus Machwirth, Dorothee Haas, Marco Pezzullo, Gabriella Pietra, Melania Grottoli, Stephanie Buart, Erwan Mortier, Enrico Maggi, Lorenzo Moretta, Ignazio Caruana & Bruno Azzarone. (2023) The roles of different forms of IL-15 in human melanoma progression. Frontiers in Immunology 14.
Crossref
Crossref
Yangyihua Zhou, Guiqi Quan, Yujun Liu, Ning Shi, Yahui Wu, Ran Zhang, Xiang Gao & Longlong Luo. (2023) The application of Interleukin-2 family cytokines in tumor immunotherapy research. Frontiers in Immunology 14.
Crossref
Crossref
Madhuparna Nandi, Amit Ghosh, Sara Ali Akbari, Diwakar Bobbala, Marie-Josée Boucher, Alfredo Menendez, Trang Hoang, Subburaj Ilangumaran & Sheela Ramanathan. (2023) IL-15 Prevents the Development of T-ALL from Aberrant Thymocytes with Impaired DNA Repair Functions and Increased NOTCH1 Activation. Cancers 15:3, pages 671.
Crossref
Crossref
Zhiwen Luo, Zhong He, Haocheng Qin, Yisheng Chen, Beijie Qi, Jinrong Lin, Yaying Sun, Junming Sun, Xiaoping Su, Ziwen Long & Shiyi Chen. (2022) Exercise-induced IL-15 acted as a positive prognostic implication and tumor-suppressed role in pan-cancer. Frontiers in Pharmacology 13.
Crossref
Crossref
Eimear Mylod, Joanne Lysaght & Melissa J. Conroy. (2022) Natural killer cell therapy: A new frontier for obesity-associated cancer. Cancer Letters 535, pages 215620.
Crossref
Crossref
Mahshid Zarrineh, Shahrbanou Ashrafian, Pia Jensen, Arkadiusz Nawrocki, Alireza Madjid Ansari, Hassan Rezadoost, Alireza Ghassempour & Martin R. Larsen. (2022) Comprehensive proteomics and sialiomics of the anti-proliferative activity of safranal on triple negative MDA-MB-231 breast cancer cell lines. Journal of Proteomics 259, pages 104539.
Crossref
Crossref
Suheil Albert Atallah-Yunes & Michael J. Robertson. (2022) Cytokine Based Immunotherapy for Cancer and Lymphoma: Biology, Challenges and Future Perspectives. Frontiers in Immunology 13.
Crossref
Crossref
Melissa M. Berrien-Elliott, Michelle Becker-HapakAmanda F. CashenMiriam Jacobs, Pamela Wong, Mark FosterEthan McClainSweta Desai, Patrick Pence, Sarah CooleyClaudio BrunsteinFeng GaoCamille N. AbboudGeoffrey L. Uy, Peter WesterveltMeagan A. JacobyIskra PusicKeith E. Stockerl-GoldsteinMark A. SchroederJohn F. DiPersioPatrick Soon-Shiong, Jeffrey S. MillerTodd A. Fehniger. (2022) Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy. Blood 139:8, pages 1177-1183.
Crossref
Crossref
Eimear Mylod, Fiona O’Connell, Noel E. Donlon, Christine Butler, John V. Reynolds, Joanne Lysaght & Melissa J. Conroy. (2021) The Omentum in Obesity-Associated Cancer: A Hindrance to Effective Natural Killer Cell Migration towards Tumour Which Can Be Overcome by CX3CR1 Antagonism. Cancers 14:1, pages 64.
Crossref
Crossref
Huan Xu, Mingyang Shi, Changsheng Shao, Hao Li, Jing Wu, Yin Yu, Fang Fang, Yugang Guo & Weihua Xiao. (2021) Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives. Microbial Cell Factories 20:1.
Crossref
Crossref
Daniel Fowler, Callum Nattress, Alba Southern Navarrete, Marta Barisa & Jonathan Fisher. (2021) Payload Delivery: Engineering Immune Cells to Disrupt the Tumour Microenvironment. Cancers 13:23, pages 6000.
Crossref
Crossref
Riccardo Corbellari, Marco Stringhini, Jaqueline Mock, Tiziano Ongaro, Alessandra Villa, Dario Neri & Roberto De Luca. (2021) A Novel Antibody–IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis. Molecular Cancer Therapeutics 20:5, pages 859-871.
Crossref
Crossref
Kyle P. D’mello, Lei Zhao, Erin C. Kaser, Ziwen Zhu, Huaping Xiao, Mark R. Wakefield, Qian Bai & Yujiang Fang. (2021) The role of interleukins and the widely studied TNF-α in non-Hodgkin’s lymphoma. Medical Oncology 38:5.
Crossref
Crossref
Xiang Wang & Xiang-Yu Zhao. (2021) Transcription Factors Associated With IL-15 Cytokine Signaling During NK Cell Development. Frontiers in Immunology 12.
Crossref
Crossref
Yu-Mei Liao, Tsai-Hsien Hung, John K. Tung, John Yu, Ya-Ling Hsu, Jung-Tung Hung & Alice L. Yu. (2021) Low Expression of IL-15 and NKT in Tumor Microenvironment Predicts Poor Outcome of MYCN-Non-Amplified Neuroblastoma. Journal of Personalized Medicine 11:2, pages 122.
Crossref
Crossref
Piera Filomena Fiore, Sabina Di Matteo, Nicola Tumino, Francesca Romana Mariotti, Gabriella Pietra, Selene Ottonello, Simone Negrini, Barbara Bottazzi, Lorenzo Moretta, Erwan Mortier & Bruno Azzarone. (2020) Interleukin-15 and cancer: some solved and many unsolved questions. Journal for ImmunoTherapy of Cancer 8:2, pages e001428.
Crossref
Crossref
Thomas A. Waldmann, Milos D. Miljkovic & Kevin C. Conlon. (2020) Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer. Journal of Experimental Medicine 217:1.
Crossref
Crossref
Christina Sakellariou, Oussama Elhage, Efthymia Papaevangelou, Giulio Giustarini, Ana M. Esteves, Dorota Smolarek, Richard A. Smith, Prokar Dasgupta & Christine Galustian. (2019) Prostate cancer cells enhance interleukin‐15‐mediated expansion of NK cells. BJU International 125:1, pages 89-102.
Crossref
Crossref
Raki Sudan. 2020. Systems and Synthetic Immunology. Systems and Synthetic Immunology
255
269
.
Jonas RM Van Audenaerde, Elly Marcq, Bianca Scheidt, Ashleigh S Davey, Amanda J Oliver, Jorrit De Waele, Delphine Quatannens, Jinthe Van Loenhout, Patrick Pauwels, Geert Roeyen, Filip Lardon, Clare Y Slaney, Marc Peeters, Michael H Kershaw, Phillip K Darcy & Evelien LJM Smits. (2020) Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment. Clinical & Translational Immunology 9:8.
Crossref
Crossref
Robert J Hennessy, Kim Pham, Rebecca Delconte, Jai Rautela, Philip D Hodgkin & Nicholas D Huntington. (2019) Quantifying NK cell growth and survival changes in response to cytokines and regulatory checkpoint blockade helps identify optimal culture and expansion conditions. Journal of Leukocyte Biology 105:6, pages 1341-1354.
Crossref
Crossref
Joana R. Lérias, Georgia Paraschoudi, Inês Silva, João Martins, Eric de Sousa, Carolina Condeço, Nuno Figueiredo, Carlos Carvalho, Ernest Dodoo, Elke Jäger, Martin Rao & Markus Maeurer. (2019) Clinically Relevant Immune Responses against Cytomegalovirus: Implications for Precision Medicine. International Journal of Molecular Sciences 20:8, pages 1986.
Crossref
Crossref
Liya Zhu, Senthilkumar Kalimuthu, Ji Min Oh, Prakash Gangadaran, Se Hwan Baek, Shin Young Jeong, Sang-Woo Lee, Jaetae Lee & Byeong-Cheol Ahn. (2019) Enhancement of antitumor potency of extracellular vesicles derived from natural killer cells by IL-15 priming. Biomaterials 190-191, pages 38-50.
Crossref
Crossref
Zhenguang Wang & Weidong Han. (2018) Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy. Biomarker Research 6:1.
Crossref
Crossref
Jiajing Qiu, Mohamed E. Salama, Cing Siang Hu, Yan Li, Xiaoli Wang & Ronald Hoffman. (2018) The characteristics of vessel lining cells in normal spleens and their role in the pathobiology of myelofibrosis. Blood Advances 2:10, pages 1130-1145.
Crossref
Crossref
Jai Rautela, Fernando Souza-Fonseca-Guimaraes, Soroor Hediyeh-Zadeh, Rebecca B Delconte, Melissa J Davis & Nicholas D Huntington. (2018) Molecular insight into targeting the NK cell immune response to cancer. Immunology and Cell Biology 96:5, pages 477-484.
Crossref
Crossref
John M. WrangleAlicia PattersonC. Bryce JohnsonDaniel J. NeitzkeShikhar MehrotraChadrick E. DenlingerChrystal M. PaulosZihai LiDavid J. ColeMark P. Rubinstein. (2018) IL-2 and Beyond in Cancer Immunotherapy. Journal of Interferon & Cytokine Research 38:2, pages 45-68.
Crossref
Crossref
Christian Fercher, Sahar Keshvari, Michael A McGuckin & Ross T Barnard. (2017) Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins. Experimental Biology and Medicine 243:2, pages 166-183.
Crossref
Crossref
Martin Rao, Liu Zhenjiang, Qingda Meng, Georges Sinclair, Ernest Dodoo & Markus Maeurer. 2018. Oncoimmunology. Oncoimmunology
41
67
.
Renee N. Donahue, Lauren M. Lepone, Italia Grenga, Caroline Jochems, Massimo Fantini, Ravi A. Madan, Christopher R. Heery, James L. Gulley & Jeffrey Schlom. (2017) Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody. Journal for ImmunoTherapy of Cancer 5:1.
Crossref
Crossref
Jörg U. Schmohl, Martin Felices, Felix Oh, Alexander J. Lenvik, Aaron M. Lebeau, Jayanth Panyam, Jeffrey S. Miller & Daniel A. Vallera. (2017) Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity. Cancer Research and Treatment 49:4, pages 1140-1152.
Crossref
Crossref
Julia A. Wagner, Maximillian Rosario, Rizwan Romee, Melissa M. Berrien-Elliott, Stephanie E. Schneider, Jeffrey W. Leong, Ryan P. Sullivan, Brea A. Jewell, Michelle Becker-Hapak, Timothy Schappe, Sara Abdel-Latif, Aaron R. Ireland, Devika Jaishankar, Justin A. King, Ravi Vij, Dennis Clement, Jodie Goodridge, Karl-Johan Malmberg, Hing C. Wong & Todd A. Fehniger. (2017) CD56bright NK cells exhibit potent antitumor responses following IL-15 priming. Journal of Clinical Investigation 127:11, pages 4042-4058.
Crossref
Crossref
Heleen H. Van Acker, Anna Capsomidis, Evelien L. Smits & Viggo F. Van Tendeloo. (2017) CD56 in the Immune System: More Than a Marker for Cytotoxicity?. Frontiers in Immunology 8.
Crossref
Crossref
James N. KochenderferRobert P.T. SomervilleTangying LuVictoria ShiAdrian BotJohn RossiAllen XueStephanie L. GoffJames C. YangRichard M. SherryChristopher A. KlebanoffUdai S. KammulaMarika ShermanArianne PerezConstance M. YuanTatyana FeldmanJonathan W. FriedbergMark J. RoschewskiSteven A. FeldmanLori McIntyreMary Ann ToomeySteven A. Rosenberg. (2017) Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels. Journal of Clinical Oncology 35:16, pages 1803-1813.
Crossref
Crossref
Stefan Rose‐John. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences
1
8
.
Krizia Rohena-Rivera, María M. Sánchez-Vázquez, Diana A. Aponte-Colón, Ingrid S. Forestier-Román, Mario E. Quintero-Aguiló & Magaly Martínez-Ferrer. (2017) IL-15 regulates migration, invasion, angiogenesis and genes associated with lipid metabolism and inflammation in prostate cancer. PLOS ONE 12:4, pages e0172786.
Crossref
Crossref
Jai Rautela & Nicholas D Huntington. (2017) IL-15 signaling in NK cell cancer immunotherapy. Current Opinion in Immunology 44, pages 1-6.
Crossref
Crossref
Tao Zhang, Yuan Liu, Xu Peng, Junwei Fan & Zhihai Peng. (2017) Association between Recipient IL-15 Genetic Variant and the Prognosis of HBV-Related Hepatocellular Carcinoma after Liver Transplantation. Disease Markers 2017, pages 1-8.
Crossref
Crossref
Zhi-xiang Yuan, Jingxin Mo, Guixian Zhao, Gang Shu, Hua-lin Fu & Wei Zhao. (2016) Targeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem Cells. Frontiers in Pharmacology 7.
Crossref
Crossref
Joerg U. Schmohl, Martin Felices, Deborah Todhunter, Elizabeth Taras, Jeffrey S. Miller & Daniel A. Vallera. (2016) Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linker. Oncotarget 7:45, pages 73830-73844.
Crossref
Crossref
Camille Guillerey, Nicholas D Huntington & Mark J Smyth. (2016) Targeting natural killer cells in cancer immunotherapy. Nature Immunology 17:9, pages 1025-1036.
Crossref
Crossref
Daniel A. Vallera, Martin Felices, Ron McElmurry, Valarie McCullar, Xianzheng Zhou, Joerg Uwe Schmohl, Bin Zhang, Alexander J. Lenvik, Angela Panoskaltsis-Mortari, Michael R. Verneris, Jakub Tolar, Sarah Cooley, Daniel J. Weisdorf, Bruce R. Blazar & Jeffrey S. Miller. (2016)
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence,
In Vivo
Expansion, and Enhanced Function
. Clinical Cancer Research 22:14, pages 3440-3450.
Crossref
Crossref
Joerg U Schmohl, Martin Felices, Elizabeth Taras, Jeff S Miller & Daniel A Vallera. (2016) Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker. Molecular Therapy 24:7, pages 1312-1322.
Crossref
Crossref
Manja Idorn & Pernille Hojman. (2016) Exercise-Dependent Regulation of NK Cells in Cancer Protection. Trends in Molecular Medicine 22:7, pages 565-577.
Crossref
Crossref
Jörg Schmohl & Daniel Vallera. (2016) CD133, Selectively Targeting the Root of Cancer. Toxins 8:6, pages 165.
Crossref
Crossref
Maximillian Rosario, Bai Liu, Lin Kong, Lynne I. Collins, Stephanie E. Schneider, Xiaoyue Chen, Kaiping Han, Emily K. Jeng, Peter R. Rhode, Jeffrey W. Leong, Timothy Schappe, Brea A. Jewell, Catherine R. Keppel, Keval Shah, Brian Hess, Rizwan Romee, David R. Piwnica-Worms, Amanda F. Cashen, Nancy L. Bartlett, Hing C. Wong & Todd A. Fehniger. (2016)
The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and
In Vivo
Clearance of B Cell Lymphomas
. Clinical Cancer Research 22:3, pages 596-608.
Crossref
Crossref
Antonio Pérez-Martínez, Lucía Fernández, Jaime Valentín, Isabel Martínez-Romera, María Dolores Corral, Manuel Ramírez, Lorea Abad, Sandra Santamaría, Marta González-Vicent, Sara Sirvent, Julián Sevilla, José Luis Vicario, Inmaculada de Prada & Miguel Ángel Diaz. (2015) A phase I/II trial of interleukin-15–stimulated natural killer cell infusion after haplo-identical stem cell transplantation for pediatric refractory solid tumors. Cytotherapy 17:11, pages 1594-1603.
Crossref
Crossref
Benjamin Boyerinas, Caroline Jochems, Massimo Fantini, Christopher R. Heery, James L. Gulley, Kwong Yok Tsang & Jeffrey Schlom. (2015) Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells. Cancer Immunology Research 3:10, pages 1148-1157.
Crossref
Crossref
Seul-Ah Lee, Jae-Sung Kim, Sun-Young Park, Heung-Joong Kim, Sun-Kyoung Yu, Chun Sung Kim, Hong Sung Chun, Jeongsun Kim, Jong-Tae Park, Daesan Go & Do Kyung Kim. (2015) miR-203 downregulates Yes-1 and suppresses oncogenic activity in human oral cancer cells. Journal of Bioscience and Bioengineering 120:4, pages 351-358.
Crossref
Crossref
Cyril Seillet, Gabrielle T. Belz & Nicholas D. Huntington. 2016. Natural Killer Cells. Natural Killer Cells
37
61
.